Adagio Medical Holdings (ADGM) Return on Sales (2023 - 2025)

Adagio Medical Holdings (ADGM) has 3 years of Return on Sales data on file, last reported at 2.31% in Q4 2025.

• For the quarter ending Q4 2025, Return on Sales changed N/A year-over-year to 2.31%; the trailing twelve-month figure through Dec 2025 stood at 2.31% (changed N/A YoY), and the FY2024 full-year result was 2.35%, down 35.0% from the prior year.
• Return on Sales fell to 2.31% in Q4 2025, from 0.67% in the prior quarter.
• In the past five years, Return on Sales ranged from a high of 0.36% in Q3 2024 to a low of 3.68% in Q1 2024.
• A 3-year average of 1.58% and a median of 1.22% in 2024 frame the typical range for Return on Sales.
• Peak annual rise in Return on Sales reached 254 bps in 2025, while the deepest fall reached 31 bps in 2025.
• Tracing ADGM's Return on Sales over 3 years: stood at 0.88% in 2023, then surged by 59 bps to 0.36% in 2024, then sank by 540 bps to 2.31% in 2025.
• Business Quant data shows ADGM's Return on Sales at 2.31% in Q4 2025, 0.67% in Q3 2025, and 1.14% in Q1 2025.